Alan Menter - Articles and news items

Janssen Pharmaceuticals Logo

New findings from the Psoriasis Longitudinal Assessment and Registry (psolar) show persistency difference among biologic therapies

Industry news / 14 October 2014 / Janssen

Persistence of STELARA® (ustekinumab) significantly better than anti-TNFs in treatment of psoriasis according to observational study analysis…

Sandoz launches Phase III clinical trial for biosimilar etanercept

Industry news, News / 24 June 2013 / Novartis

Sandoz has initiated a major Phase III clinical trial with its biosimilar version of etanercept (Amgen’s Enbrel®)…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...